Complete Genomics Competitors and Similar CompaniesClear all

Complete Genomics's competitors and similar companies include Personalis, Oxford Nanopore Technologies, 23andMe and Natera.
Complete Genomics
Complete Genomics
Complete Genomics is a company that develops sequencing solutions for laboratories.
Personalis
Personalis
Personalis is a biotechnology company that specializes in cancer genomics.
Oxford Nanopore Technologies
Oxford Nanopore Technologies
Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules.
23andMe
23andMe
23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.
Natera
Natera
Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.
Founding Date
Founding Date
2005
Founding Date
2011
Founding Date
2005
Founding Date
2006
Founding Date
2004
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Jose, US HQ
Locations
Fremont, US HQ
West Wickham, GB
Locations
Oxford, GB HQ
Beijing, CN
Shanghai, CN
Tokyo, JP
Singapore, SG
Abu Dhabi, AE
Didcot, GB
see more
Locations
Sunnyvale, US HQ
South San Francisco, US
Locations
Austin, US HQ
San Carlos, US
Employees
Employees
2361% decrease
Employees
22344% decrease
Employees
1,382
Employees
56027% decrease
Employees
3,28211% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
340.9 m
Valuation ($)
1.8 b
Valuation ($)
169.1 m
Valuation ($)
15.4 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$69.6m (FY, 2025)
Revenue (est.)
£223.9m (FY, 2025)
Revenue (est.)
$189.9m (FY, 2025)
Revenue (est.)
$2.3b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$53.9m (FY, 2025)
Cost of goods
£42.8m (FY, 2025)
Cost of goods
$89.9m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$15.8m (FY, 2025)
Gross profit
£181.1m (FY, 2025)
Gross profit
$100m (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
($81.3m) (FY, 2025)
Net income
(£145.2m) (FY, 2025)
Net income
($280.9m) (FY, 2025)
Net income
($208.2m) (FY, 2025)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
120 (FY, 2021)
Countries
50 (Apr, 2020)
Countries
N/A
Patent Applications
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
7 (Apr, 2020)
Patent Applications
100 (FY, 2021)
Patents Issued
Patents Issued
N/A
Patents Issued
16 (FY, 2021)
Patents Issued
N/A
Patents Issued
93 (FY, 2022)
Patents Issued
200 (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 143m
Total funding raised
$ 75m
Total funding raised
$ 1.3b
Total funding raised
$ 912.5m
Total funding raised
$ 154.1m
For sources of this data, please see the company profile

View Company Profiles

Personalis
HQ
Fremont, US
Employees
223↓ 44% decrease

Personalis is a biotechnology company that specializes in cancer genomics.

View company
Oxford Nanopore Technologies
HQ
Oxford, GB
Employees
1,382

Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules.

View company
23andMe
HQ
Sunnyvale, US
Employees
560↓ 27% decrease

23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.

View company
Natera
HQ
Austin, US
Employees
3,282↑ 11% increase

Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.

View company